Date: 2018-01-02
Type of information: Nomination
Compound:
- chief business officer - vice president - clinical and regulatory strategist
Company: LogicBio Therapeutics (USA - MA)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On January 2, 2018, LogicBio Therapeutics announced the expansion of its leadership team with the appointment of four seasoned industry leaders:
- - Matthias Jaffe as Chief Financial Officer. Over the last 15 years, Jaffe has served as CFO for Constellation Pharmaceuticals, Zafgen, Pervasis Therapeutics and Alantos Pharmaceuticals. Previously he worked in venture capital and management consulting at Earlybird Venture Capital and the Boston Consulting Group respectively. He holds an M.Sc. from MIT and an MBA from INSEAD.
- - Tom Wilton as Chief Business Officer. Previously, Tom Wilton served as chief business officer for the University of Pennsylvania’s Gene Therapy Program, and played an instrumental role in the establishment of GSK’s Rare Diseases Business Unit. He holds an M.A. in health systems research from the University of Leeds and an M.Sc. in strategic technology management from Brunel University
- - Nelson Chau as Vice President, Biology. Prior to joining LogicBio, Nelson Chau served as vice president of drug discovery at Translate Bio and director of research at Regulus Therapeutics, where he contributed to the discovery and preclinical development of multiple RNA-based therapeutics. Chau earned his Ph.D. from the Johns Hopkins School of Medicine.
-
- Kelly Blackburn as Clinical and Regulatory Strategist. Kelly Blackburn began her career at Rhone-Poulenc, Bayer and Genetics Institute, and later went on to drive clinical development programs at aTyr Pharma, Vertex and Millennium Pharmaceuticals. She holds a B.S. in biochemistry from the University of New Hampshire and an M.H.A. from Quinnipiac University.
- In June 2017, LogicBio Therapeutics has completed a Series B financing.
Financial terms:
Latest news:
Is general: Yes
